Joseph Andrew Blanton, LCSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 227 Metro Dr, Jefferson City, MO 65109 Phone: 888-403-1071 |
Peg Noordster, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 211 Oscar Dr, Suite A, Jefferson City, MO 65101 Phone: 573-635-8299 Fax: 573-635-4629 |
Mrs. Jeanine Taylor Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 211 Oscar Dr, Suite A, Jefferson City, MO 65101 Phone: 573-635-8299 Fax: 573-635-4629 |
Don Carter Jr., BSW, MSW, LCSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 227 Metro Dr, Jefferson City, MO 65109 Phone: 888-403-1071 |
News Archive
Surgeons battle time and the body's defenses as they stitch together veins and arteries, whether after an injury or in the course of such treatments as transplants or bypasses. Loss of blood before a site is closed and too much clotting soon after challenge medical care.
Researchers at the University of Florida and Xhale have developed a breath-monitoring device that can detect whether people living with HIV/AIDS adhere to their treatment regimens, ANI/Thaindian News reports.
A new study revealed that your cereal choice at breakfast might have an impact on how much you eat for lunch. Newly published research in the Journal of the American College of Nutrition showed that a hearty bowl of instant oatmeal helped curb food intake at lunch better than a leading oat-based, cold cereal - even when each bowl provided the same number of calories.
The hepatitis C virus is highly specialised. We humans are its natural hosts. The only other living organisms that could be infected with the hepatitis C virus in the lab are chimpanzees. Nevertheless it is - from the viewpoint of the virus - highly successful: around 170 million people are chronically infected with the virus. And with the chronic infection the risk of developing liver cancer also increases.
RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), announced today that it has entered into a research collaboration with Mirna Therapeutics (Austin, TX), to determine the utility of combining RXi's proprietary rxRNA™ technology with Mirna's microRNA mimics as potential therapeutics in oncology. The parties will each contribute technology and resources to the collaboration to generate and evaluate novel microRNA compounds.
› Verified 2 days ago